Hantavirus-specific IgA in saliva and viral antigen in the parotid gland in patients with hemorrhagic fever with renal syndrome

Journal of Medical Virology

Volumn 83, Issue 5, 2011, Pages 864-870

  Pettersson, Lisa ^a   Rasmuson, Johan ^a   Andersson, Charlotta ^a   Ahlm, Clas ^a   Evander, Magnus ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Antibody; HCPS; HFRS; Puumalavirus; Transmission; Zoonosis

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HANTAVIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PAROTID GLAND; REAL TIME POLYMERASE CHAIN REACTION; SALIVA; SALIVA ANALYSIS; SALIVA LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PAROTID GLAND; PUUMALA VIRUS; RNA, VIRAL; SALIVA;

BUNYAVIRIDAE; HANTAVIRUS; PUUMALA VIRUS; RODENTIA;

EID: 79952721391     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22040     Document Type: Article

References (39)

1. Belec L, Legoff J, Si-Mohamed A, Bloch F, Mbopi Keou FX, Becquart P, Matta M, Prazuck T, Petite JP, Gutmann L, Payan C. 2003. Mucosal humoral immune response to hepatitis C virus E1/E2 surface glycoproteins and HCV shedding in saliva and cervicovaginal fluids from chronically HCV-infected patients. J Hepatol 38: 833-842.
2. Biesbrock AR, Reddy MS, Levine MJ. 1991. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun 59: 3492-3497.
3. Botten J, Mirowsky K, Kusewitt D, Bharadwaj M, Yee J, Ricci R, Feddersen RM, Hjelle B. 2000. Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc Natl Acad Sci USA 97: 10578-10583.
4. Brandtzaeg P. 2007. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann N Y Acad Sci 1098: 288-311.
5. Compton SR, Jacoby RO, Paturzo FX, Smith AL. 2004. Persistent Seoul virus infection in Lewis rats. Arch Virol 149: 1325-1339.
6. Corstjens P, Malamud D. 2008. Point-of-care diagnostics for infectious diseases. In: Wong D. editor. Salivary diagnostics. Ames, Iowa, USA: Wiley-Blackwell. pp. 140-143.
7. de Carvalho Nicacio C, Lundkvist A, Sjolander KB, Plyusnin A, Salonen EM, Bjorling E. 2000. A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus. J Med Virol 60: 446-454.
8. Devito C, Hinkula J, Kaul R, Kimani J, Kiama P, Lopalco L, Barass C, Piconi S, Trabattoni D, Bwayo JJ, Plummer F, Clerici M, Broliden K. 2002. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J Acquir Immune Defic Syndr 30: 413-420.
9. Douron E, Moriniere B, Matheron S, Girard PM, Gonzalez JP, Hirsch F, McCormick JB. 1984. HFRS after a wild rodent bite in the Haute-Savoie-And risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet 1: 676-677.
10. Elgh F, Linderholm M, Wadell G, Tarnvik A, Juto P. 1998. Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol Med Microbiol 22: 309-315.
11. Evander M, Eriksson I, Pettersson L, Juto P, Ahlm C, Olsson GE, Bucht G, Allard A. 2007. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 45: 2491-2497.
12. Ferres M, Vial P, Marco C, Yanez L, Godoy P, Castillo C, Hjelle B, Delgado I, Lee SJ, Mertz GJ. 2007. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile. J Infect Dis 195: 1563-1571.
13. Fox PC, Wolff A, Yeh CK, Atkinson JC, Baum BJ. 1988. Saliva inhibits HIV-1 infectivity. J Am Dent Assoc 116: 635-637.
14. Groen J, Gerding M, Jordans JG, Clement JP, Osterhaus AD. 1994. Class and subclass distribution of hantavirus-specific serum antibodies at different times after the onset of nephropathia epidemica. J Med Virol 43: 39-43.
15. Habte HH, Mall AS, de Beer C, Lotz ZE, Kahn D. 2006. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of human immunodeficiency virus type 1 in an inhibition assay. Virol J 3: 99.
16. Hardestam J, Karlsson M, Falk KI, Olsson G, Klingstrom J, Lundkvist A. 2008a Puumala hantavirus excretion kinetics in bank voles (Myodes glareolus). Emerg Infect Dis 14: 1209-1215.
17. Hardestam J, Petterson L, Ahlm C, Evander M, Lundkvist A, Klingstrom J. 2008b Antiviral effect of human saliva against hantavirus. J Med Virol 80: 2122-2126.
18. Hardestam J, Lundkvist A, Klingstrom J. 2009. Sensitivity of Andes hantavirus to antiviral effect of human saliva. Emerg Infect Dis 15: 1140-1142.
19. Hartshorn KL, Ligtenberg A, White MR, Van Eijk M, Hartshorn M, Pemberton L, Holmskov U, Crouch E. 2006. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem J 393: 545-553.
20. Hocini H, Belec L, Iscaki S, Garin B, Pillot J, Becquart P, Bomsel M. 1997. High-level ability of secretory IgA to block HIV type 1 transcytosis: Contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Hum Retroviruses 13: 1179-1185.
21. Johansson P, Olsson M, Lindgren L, Ahlm C, Elgh F, Holmstrom A, Bucht G. 2004. Complete gene sequence of a human Puumala hantavirus isolate, Puumala Umea/hu: Sequence comparison and characterisation of encoded gene products. Virus Res 105: 147-155.
22. Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. 1996. Pulmonary involvement in nephropathia epidemica: Radiological findings and their clinical correlations. Clin Nephrol 46: 369-378.
23. Lee HW, Lee PW, Baek LJ, Song CK, Seong IW. 1981. Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius Am J Trop Med Hyg 30: 1106-1112.
24. Ligtenberg AJ, Bikker FJ, De Blieck-Hogervorst JM, Veerman EC, Nieuw Amerongen AV. 2004. Binding of salivary agglutinin to IgA. Biochem J 383: 159-164.
25. Linderholm M, Bjermer L, Juto P, Roos G, Sandstrom T, Settergren B, Tarnvik A. 1993. Local host response in the lower respiratory tract in nephropathia epidemica. Scand J Infect Dis 25: 639-646.
26. Linderholm M, Sandstrom T, Rinnstrom O, Groth S, Blomberg A, Tarnvik A. 1997. Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis 25: 1084-1089.
27. Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB, Lehner T. 1998. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med 4: 601-606.
28. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, Padula PJ, 2005. Person-to-person transmission of Andes virus. Emerg Infect Dis 11: 1848-1853.
29. Meisel H, Wolbert A, Razanskiene A, Marg A, Kazaks A, Sasnauskas K, Pauli G, Ulrich R, Kruger DH. 2006. Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins. Clin Vaccine Immunol 13: 1349-1357.
30. Moja P, Tranchat C, Tchou I, Pozzetto B, Lucht F, Desgranges C, Genin C. 2000. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients. J Infect Dis 181: 1607-1613.
31. Nugent CT, Dockter J, Bernardin F, Hecht R, Smith D, Delwart E, Pilcher C, Richman D, Busch M, Giachetti C. 2009. Detection of HIV-1 in alternative specimen types using the APTIMA HIV-1 RNA qualitative assay. J Virol Methods 159: 10-14.
32. Padula PJ, Rossi CM, Della Valle MO, Martinez PV, Colavecchia SB, Edelstein A, Miguel SD, Rabinovich RD, Segura EL. 2000. Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol 49: 149-155.
33. Padula P, Figueroa R, Navarrete M, Pizarro E, Cadiz R, Bellomo C, Jofre C, Zaror L, Rodriguez E, Murua R. 2004. Transmission study of Andes hantavirus infection in wild sigmodontine rodents. J Virol 78: 11972-11979.
34. Pettersson L, Klingstrom J, Hardestam J, Lundkvist A, Ahlm C, Evander M. 2008. Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome. Emerg Infect Dis 14: 406-411.
35. Renegar KB, Small PA, Jr, Boykins LG, Wright PF. 2004. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 173: 1978-1986.
36. Russel MW. 2007. Biological function of IgA. In: Kaetzel C. editor. Mucosal immune defense: Immunoglobulin A. New York: Springer Science. pp. 144-172.
37. Saksida A, Duh D, Korva M, Avsic-Zupanc T. 2008. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis 197: 681-685.
38. St Jeor SC. 2004. Three-week incubation period for hantavirus infection. Pediatr Infect Dis J 23: 974-975.
39. Wickstrom C, Christersson C, Davies JR, Carlstedt I. 2000. Macromolecular organization of saliva: Identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase. Biochem J 351: 421-428.